Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » GE Healthcare

GE Healthcare

Mar 02, 2020

RevoluGen, GE Healthcare Life Sciences Ink DNA Extraction Product Manufacturing Deal

The product uses spin columns to extract high molecular weight DNA with an average length of 100 kb or more from animal and bacterial cells.

Sep 11, 2019

Roche-GE Partnership Integrating Molecular Data Into Navify Tumor Board

Premium

The partners are preparing to release two updates to Navify Tumor Board that support automatic importation of structured Foundation Medicine test reports.

Dec 31, 2015

NeoGenomics Completes Clarient Acquisition

The cancer genetics testing provider acquired its new business unit from GE Healthcare.

Oct 28, 2015

With Clarient Purchase, NeoGenomics Hoping to Offer Most Comprehensive Cancer Genetics Test Menu

Premium

By buying Clarient, NeoGenomics hopes to move closer to its goal of becoming America's top cancer genetic testing lab.

Oct 21, 2015

NeoGenomics to Acquire Clarient From GE

NeoGenomics and GE Healthcare will also collaborate on a bioinformatics initiative for personalized oncology.

Jul 14, 2015

Axiogenesis Inks Sublicensing Agreement with GE Healthcare for Stem Cell IP

The deal gives Axiogenesis access to IP that will allow it to commercialize stem cell-derived assays and disease models for use in drug discovery.

Dec 04, 2014

Broad Licenses CRISPR/Cas9 IP to GE Healthcare, Sigma-Aldrich

The licenses provide non-exclusive access to the IP for research applications.

Nov 04, 2014

IP Roundup: GE, Luminex, and University of Tokyo Win US Patents

Premium

General Electric has been awarded

Oct 08, 2014

GE/Clarient Setting Up Lab Network, Database to Advance Personalized Rx for GSK, Other Pharmas

Premium

Originally published Oct. 3.

Sep 30, 2014

GE Healthcare's Clarient, GSK Creating Clinical Lab Network to Improve Cancer Dx

NEW YORK (GenomeWeb) – GE Healthcare today announced a deal between its affiliate Clarient Diagnostic Services and GlaxoSmithKline to create a network of clinical laboratories to identify genetic mutations associated with different tumor types.

Pages

The Scan

Preprints During Lockdown

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

ApoE and COVID-19

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Search for Genetic Clues to COVID-19 Severity

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

PNAS Papers on Retinal Development, Adoptive T Cell Transfer, Blood Cell Differentiation

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.